Magellan Health Reports First Quarter 2021 Financial Results

Go back to Magellan Health Reports First Quarter 2021 Financial Results

Magellan Health (MGLN) Tops Q4 EPS by 66c

April 30, 2021 6:43 AM EDT

Magellan Health (NASDAQ: MGLN) reported Q4 EPS of $1.33, $0.66 better than the analyst estimate of $0.67. Revenue for the quarter came in at $1.16 million versus the consensus estimate of $1.14 million.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

... More